adamantane has been researched along with Hyperlipemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SW; Dal Nam, K; Hahn, HG; Je Lee, W; Kim, EA; Yang, SJ; Young Choi, S | 1 |
| Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D | 1 |
| Bhullar, H; Carbonari, DM; Cardillo, S; Esposito, DB; Gallagher, AM; Haynes, K; Hennessy, S; Holick, CN; Lo Re, V; Newcomb, CW; Nezamzadeh, MS; Roy, JA; Saine, ME; Strom, BL | 1 |
| Aerts, JM; Bietrix, F; Groen, AK; Lombardo, E; Ottenhoff, R; Rensen, PC; van Roomen, CP; Verhoeven, AJ; Vos, M | 1 |
| Barbosa-Sicard, E; Brandes, RP; Fleming, I; Geisslinger, G; Hammock, BD; Liebner, S; Mieth, A; Morisseau, C; Revermann, M; Schermuly, RT; Schloss, M | 1 |
| Matikainen, N; Taskinen, MR | 1 |
| Day, CE; Schurr, PE | 1 |
2 trial(s) available for adamantane and Hyperlipemia
| Article | Year |
|---|---|
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Intention to Treat Analysis; Male; Metformin; Middle Aged; Nitriles; Postprandial Period; Pyrrolidines; Sulfonylurea Compounds; Vildagliptin; Weight Gain; Weight Loss | 2014 |
The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes.
Topics: Adamantane; Biomarkers; Chylomicron Remnants; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Meals; Nitriles; Particle Size; Postprandial Period; Pyrrolidines; Triglycerides; Vildagliptin | 2013 |
5 other study(ies) available for adamantane and Hyperlipemia
| Article | Year |
|---|---|
Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Interleukin-1beta; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Thiazoles; Tumor Necrosis Factor-alpha; Vitamin E | 2014 |
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs.
Topics: Adamantane; Administration, Oral; Adolescent; Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Practice Patterns, Physicians'; United Kingdom; United States; Young Adult | 2015 |
Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Apolipoproteins E; Atherosclerosis; Bile; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Feces; Female; Glucosyltransferases; Glycosphingolipids; Hyperlipidemias; Kinetics; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Receptors, LDL | 2010 |
Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
Topics: Adamantane; Animals; Apolipoproteins E; Arachidonic Acids; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Femoral Artery; Hyperlipidemias; Hyperplasia; Inflammation Mediators; Lauric Acids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Tunica Intima | 2010 |
Response to the hypobetalipoproteinemic agent adamantyloxyphenyl piperidine in hyperlipemic rats.
Topics: Adamantane; Animals; Bridged-Ring Compounds; Cholesterol; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Liver; Male; Organ Size; Organ Specificity; Piperidines; Rats | 1977 |